Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CART-30
i
Other names:
CAR-T CD30, CART-30, CD30 chimeric antigen receptor T cell therapy
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
AbelZeta Pharma, Chinese PLA General Hospital
Drug class:
CD30-targeted CAR-T immunotherapy
Related drugs:
‹
TT11 (2)
4SCAR30273 (0)
ATLCAR.CD30 cell therapy (0)
ATLCAR.CD30.CCR4 cells (0)
CAR-T CD19/CD20/CD22/CD30 (0)
TT11X (0)
anti-CD30 CAR T cells (0)
TT11 (2)
4SCAR30273 (0)
ATLCAR.CD30 cell therapy (0)
ATLCAR.CD30.CCR4 cells (0)
CAR-T CD19/CD20/CD22/CD30 (0)
TT11X (0)
anti-CD30 CAR T cells (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
ALK positive
Non-Hodgkin’s Lymphoma
ALK positive
Non-Hodgkin’s Lymphoma
CART-30
Resistant: C4 – Case Studies
CART-30
Resistant
:
C4
CART-30
Resistant: C4 – Case Studies
CART-30
Resistant
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login